Overview

A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

Status:
COMPLETED

Trial end date:
2024-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to provide data showing if there are any effects of GSK3036656 on a combined oral contraceptive containing Ethinyl Estradiol (EE) and Levonorgestrel (LNG), which will help inform future studies on suitable contraceptive measures to be used.

Phase:

PHASE1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

ethinyl estradiol, levonorgestrel drug combination
GSK656